Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

Proteome Analysis

Below the proteome analysis is presented. The analysis methods are presented in the paper Propagating Differential Gene Expression in Protein Interaction Networks. If you are interested in the most reliable results choose the

  • value_type as 'ranked' since this provides a very robust analysis method.
  • intercation map as 'high confidence'
  • network_comparison type as 'Divided' since this leads to a natural grouping of similar proteins
  • filtered as 'true' since this will only use the microarray measurements that have a sufficiently large confidence level.

    • Navigation/Query Panel:
    Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
    Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
    Results: HTML CSV LaTeX Showing element 308 to 357 of 3228 in total 
    Value Type: Ranked
    Network Comparison Type: Divided
    Interaction Map: High confidence
    Filtered: 1
    
\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
308\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPL34\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l34. [source:swissprot;acc:p49207]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
242.153\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
266.673\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.10126\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
309\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SEC61A2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein transport protein sec61 alpha subunit isoform 2 (sec61 alpha- 2). [source:swissprot;acc:q9y2r3]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
310\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SEC61A1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein transport protein sec61 alpha subunit isoform 1 (sec61 alpha- 1). [source:swissprot;acc:p38378]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
311\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EIF1B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein translation factor sui1 homolog gc20. [source:swissprot;acc:o60739]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
242.627\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
267.151\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10108\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
312\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPL3L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l3-like. [source:swissprot;acc:q92901]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
242.195\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
266.663\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10103\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
313\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RRM2B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ribonucleotide reductase m2 b (tp53 inducible); p53-inducible ribonucleotide reductase small subunit 2 homolog. [source:refseq;acc:nm\_015713]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
232.473\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.207\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10069\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
314\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
METAP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
methionine aminopeptidase 1 (ec 3.4.11.18) (metap 1) (map 1) (peptidase m 1). [source:swissprot;acc:p53582]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
244.126\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
268.604\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.10027\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
315\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
METAP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
methionine aminopeptidase 2 (ec 3.4.11.18) (metap 2) (peptidase m 2) (initiation factor 2 associated 67 kda glycoprotein) (p67) (p67eif2). [source:swissprot;acc:p50579]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
316\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EIF1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein translation factor sui1 homolog (sui1iso1). [source:swissprot;acc:p41567]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
242.694\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
267.017\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10022\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
317\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
splicing factor 3b subunit 3 (spliceosome associated protein 130) (sap 130) (sf3b130) (pre-mrna splicing factor sf3b 130 kda subunit). [source:swissprot;acc:q15393]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.445\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.044\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09998\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
318\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MRPL3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitochondrial 60s ribosomal protein l3 (l3mt). [source:swissprot;acc:p09001]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
242.011\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
266.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09987\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
319\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPL19\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l19. [source:swissprot;acc:p14118]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
240.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
264.729\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09969\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
320\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDH1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
epithelial-cadherin precursor (e-cadherin) (uvomorulin) (cadherin-1) (cam 120/80). [source:swissprot;acc:p12830]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
241.892\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
265.96\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0995\vspace{3pt}}\\\cline{1-3}\cline{5-6}
\parbox{\wcA}{\vspace{3pt}\noindent
321\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
c367g8.3 (novel protein similar to rpl23a (60s ribosomal protein l23a)) (60s ribosomal protein l23a like). [source:sptrembl;acc:q9br02]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
265.959\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09949\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
322\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DNASE2B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
deoxyribonuclease ii beta isoform 1 precursor; deoxyribonuclease ii beta; endonuclease dlad. [source:refseq;acc:nm\_021233]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
86.7483\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
78.8995\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09948\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
323\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l23a. [source:swissprot;acc:p29316]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
241.884\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
265.945\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09947\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
324\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPS23\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s23. [source:swissprot;acc:p39028]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
243.944\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
268.195\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.09941\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
325\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MRPS12\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
28s ribosomal protein s12, mitochondrial precursor (mpr-s12) (mt- rps12). [source:swissprot;acc:o15235]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
326\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPL5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l5. [source:swissprot;acc:p46777]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
241.899\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
265.924\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09932\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
327\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
POLR2A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna-directed rna polymerase ii largest subunit (ec 2.7.7.6) (rpb1). [source:swissprot;acc:p24928]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.817\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
267.962\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09903\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
328\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DDX24\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
atp-dependent rna helicase ddx24 (dead-box protein 24). [source:swissprot;acc:q9gzr7]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
258.437\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.183\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09888\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
329\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NEUROD2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neurogenic differentiation factor 2 (neurod2). [source:swissprot;acc:q15784]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
312\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
284\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.09859\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
330\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CHD3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
chromodomain helicase-dna-binding protein 3 (chd-3) (mi-2 autoantigen 240 kda protein) (mi2-alpha). [source:swissprot;acc:q12873]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
331\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDK2AP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
doc-1 related protein (doc-1r). [source:swissprot;acc:o75956]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
332\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NEUROD6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neurogenic differentiation factor 6 (neurod6) (my051 protein). [source:swissprot;acc:q96nk8]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
333\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NEUROD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neurogenic differentiation factor 1 (neurod1) (neurod). [source:swissprot;acc:q13562]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
334\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NEUROD4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neurogenic differentiation factor 4 (neurod4). [source:swissprot;acc:q9hd90]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
335\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CHD5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
chromodomain helicase dna binding protein 5. [source:refseq;acc:nm\_015557]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
336\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDK2AP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cyclin-dependent kinase 2-associated protein 1 (cdk2-associated protein 1) (putative oral cancer suppressor) (deleted in oral cancer- 1) (doc-1). [source:swissprot;acc:o14519]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
337\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l12. [source:swissprot;acc:p30050]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
243.583\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
267.527\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0983\vspace{3pt}}}\\\cline{1-1}\cline{3-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
338\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l12 like protein. [source:sptrembl;acc:o60886]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
267.528\vspace{3pt}}&\\\cline{1-1}\cline{3-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
339\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
dj999l4.1 (novel protein similar to ribosomal protein l12 (rpl12)). [source:sptrembl;acc:q9nq02]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
267.527\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
340\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYEF2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myelin gene expression factor 2. [source:refseq;acc:nm\_016132]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
235.383\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
258.476\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09811\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
341\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l9. [source:swissprot;acc:p32969]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
240.243\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
263.798\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09805\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
342\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPS20\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s20. [source:swissprot;acc:p17075]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
267.21\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09737\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
343\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRMT3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein arginine n-methyltransferase 3 (ec 2.1.1.-) (fragment). [source:swissprot;acc:o60678]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
241.625\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
265.136\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0973\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
344\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s2 (s4) (llrep3 protein). [source:swissprot;acc:p15880]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
345\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CMPK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ump-cmp kinase (ec 2.7.4.14) (cytidylate kinase) (deoxycytidylate kinase) (cytidine monophosphate kinase). [source:swissprot;acc:p30085]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
242.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
265.697\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.09729\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
346\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPS3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s3. [source:swissprot;acc:p23396]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
241.612\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
265.119\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
347\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AK3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gtp:amp phosphotransferase mitochondrial (ec 2.7.4.10) (ak3) (adenylate kinase 3 alpha like 1). [source:swissprot;acc:q9uij7]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
242.14\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
265.697\vspace{3pt}}&\\\cline{1-3}\cline{5-6}
\parbox{\wcA}{\vspace{3pt}\noindent
348\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adenylate kinase isoenzyme 4, mitochondrial (ec 2.7.4.3) (atp-amp transphosphorylase). [source:swissprot;acc:p27144]\vspace{3pt}}&&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
265.696\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.09728\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
349\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MED22\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
surfeit locus protein 5. [source:swissprot;acc:q15528]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
350\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SCAPER\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein 291. [source:swissprot;acc:q9by12]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
351\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PEX1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
peroxisome biogenesis factor 1 (peroxin-1) (peroxisome biogenesis disorder protein 1). [source:swissprot;acc:o43933]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
352\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TXNDC9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein 1-4 (atp binding protein associated with cell differentiation). [source:swissprot;acc:o14530]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
353\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GIPC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rgs19-interacting protein 1 (gaip c-terminus interacting protein gipc) (rgs-gaip interacting protein) (tax interaction protein 2) (tip-2). [source:swissprot;acc:o14908]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
231.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.252\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.09694\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
354\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STX10\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
syntaxin 10 (syn10). [source:swissprot;acc:o60499]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
234.691\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
257.442\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
355\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STX6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
syntaxin 6. [source:swissprot;acc:o43752]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
234.673\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
257.414\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09691\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
356\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l10a (csa-19). [source:swissprot;acc:p53025]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
266.796\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09684\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
357\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l10 (qm protein) (tumor suppressor qm) (laminin receptor homolog). [source:swissprot;acc:p27635]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
266.661\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09683\vspace{3pt}}\\\hline
nd{longtable}

    Legend:
    - Rank is the rank after comparing the two networks
    
 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
    
 - Hugo is the HGNC identifier if it exists
    
 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
    
 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
    
 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
    
 - Filtered specifies whether we only included the high confidence microarry measurements or not.
    - http://analysis.yellowcouch.org/